Skip to main content
OpenTrials

Clinical trial condition

Prurigo Nodularis

Explore clinical trials studying Prurigo Nodularis. Study availability and eligibility vary by location and protocol.

35 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Prurigo Nodularis trial results

Active, not recruiting

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)

NCT06516965

Conditions
Prurigo Nodularis
Locations
  • Medical Dermatology Specialists Phoenix Phoenix, Arizona, United States
  • Investigate Md Scottsdale, Arizona, United States
  • First Oc Dermatology Research Inc Fountain Valley, California, United States
  • Clinical Science Institute Clinical Research Specialists Inc Santa Monica, California, United States
View all 119 locations
View Trial Details
Active, not recruiting

A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

NCT04204616

Conditions
Prurigo Nodularis
Locations
  • Galderma Investigational Site Birmingham, Alabama, United States
  • Galderma Investigational Site Birmingham, Alabama, United States
  • Galderma Investigational Site Fountain Valley, California, United States
  • Galderma Investigational Site Los Angeles, California, United States
View all 164 locations
View Trial Details
Active, not recruiting

Real-World Effectiveness of Dupilumab in Patients With Prurigo Nodularis: An Observational Study

NCT05991323

Conditions
Prurigo Nodularis
Locations
  • Medical Dermatology Specialists Site Number : 8400005 Phoenix, Arizona, United States
  • Saguaro Dermatology Associates, LLC - Probity - PPDS- Site Number : 8400024 Phoenix, Arizona, United States
  • Center for Dermatology Clinical Research- Site Number : 8400002 Fremont, California, United States
  • Halcyon Dermatology- Site Number : 8400023 Laguna Hills, California, United States
View all 49 locations
View Trial Details
Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases

NCT06342713

Conditions
Atopic Dermatitis, Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +15 more
Locations
  • Innovate Clinical Research Waitara, New South Wales, Australia
  • Cmax Clinical Research Adelaide, South Australia, Australia
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
View all 13 locations
View Trial Details
Completed

Study to Assess the Efficacy, Safety, and Tolerability of Vixarelimab in Reducing Pruritus in Prurigo Nodularis

NCT03816891

Conditions
Pathological Conditions, Signs and Symptoms, Prurigo Nodularis, Pruritis, +5 more
Locations
  • Arizona Research Center Phoenix, Arizona, United States
  • Investigate MD, LLC Scottsdale, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • First OC Dermatology Fountain Valley, California, United States
View all 86 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN)

NCT05764161

Conditions
Dermatitis, Prurigo, Prurigo Nodularis, +2 more
Locations
  • University of Alabama At Birmingham Birmingham, Alabama, United States
  • Northwest Arkansas Clinical Trials Center Arkansas City, Arkansas, United States
  • Dermatology Research Associates Los Angeles, California, United States
  • Clinical Science Institute Clinical Research Specialists Inc Santa Monica, California, United States
View all 76 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream

NCT06213831

Conditions
Prurigo Nodularis
Locations
  • Saguaro Dermatology Phoenix, Arizona, United States
  • Affiliated Dermatology Scottsdale, Arizona, United States
  • First Oc Dermatology Fountain Valley, California, United States
  • Amicis Research Center Valencia Northridge, California, United States
View all 20 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Prurigo Nodularis

NCT05061693

Conditions
Prurigo Nodularis
Locations
  • Investigative Site US010 Phoenix, Arizona, United States
  • Investigative Site US024 Phoenix, Arizona, United States
  • Investigative Site US001 Fountain Valley, California, United States
  • Investigative Site US014 Sacramento, California, United States
View all 49 locations
View Trial Details

Related conditions